BASF Sells Marine Biopolymers Business to Seagarden ASA
The divestment of the Chitosan business from former Cognis results from the portfolio optimization following the acquisition of Cognis by BASF in 2010.
3 Jul 2012 --- BASF SE and the Norwegian company Seagarden ASA signed a contract to transfer the Chitosan marine biopolymers business. Chitosan marine biopolymers are used in personal care products and as pharmaceutical ingredients. The transaction is expected to be formally completed by August 2012.
The divestment of the Chitosan business from former Cognis results from the portfolio optimization following the acquisition of Cognis by BASF in 2010. The Chitosan business including the production site in Tromsoe, Norway, will be owned by the Norwegian specialist for natural seafood ingredients, marine bioactives and biopolymers, Seagarden SAS through its subsidiary Chitinor AS. The customers have been informed accordingly and conditions have been fixed to ensure supply reliability through the transition.
Upcoming webinars
The new math of functional eating in the GLP-1 era: addressing texture, nutrients, and health
Jungbunzlauer
The No-Compromise Formula: Ensuring Superior Taste in Nutrition-Focused Formulations
Biospringer by Lesaffre
All about Cococa Butter Equivalents
AAK
